Shire bags a quick thumbs up for its new­ly won can­cer drug pipeline

Shire is ready to cash in its first can­cer drug chip won in its ac­qui­si­tion of Bax­al­ta.

The biotech com­pa­ny says that the EMA’s …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.